JOURNAL OF RHEUMATOLOGY, vol.34, no.3, pp.501-509, 2007 (SCI-Expanded, Scopus)
Objective. To obtain a consensus on the minimal clinically relevant treatment effect in various scleroderma disease outcome measures to be used in future clinical trials.